What is the recommended dose of IV (intravenous) ranitidine per kilogram for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Ranitidine Dosing Per Kilogram

For pediatric patients, administer IV ranitidine at 1-1.5 mg/kg every 6-8 hours, with the higher dose of 1.5 mg/kg every 6 hours preferred for critically ill children requiring reliable gastric acid suppression. 1, 2

Standard Pediatric Dosing

The FDA-approved dosing for IV ranitidine in children is 2-4 mg/kg/day divided every 6-8 hours, with a maximum single dose of 50 mg. 1 This translates to approximately 0.5-1 mg/kg per dose when given every 6-8 hours.

However, clinical evidence demonstrates this standard dosing may be insufficient:

  • For critically ill pediatric patients requiring stress ulcer prophylaxis, 1.5 mg/kg IV every 6 hours is superior to lower doses for maintaining gastric pH ≥4. 2
  • In a study of 40 critically ill children, 80% of patients receiving 1.5 mg/kg every 6 hours achieved adequate acid suppression (pH ≥4 for >80% of monitoring period), compared to lower success rates with 0.75 mg/kg every 6 hours. 2
  • Recent data from 628 critically ill pediatric patients showed that dosing more frequently than every 8 hours is necessary to maintain therapeutic gastric pH. 3

Neonatal Dosing

For neonates (especially those on ECMO), a single dose of 2 mg/kg IV is sufficient to increase gastric pH >4 for at least 15 hours. 1, 4

  • Administer 2 mg/kg every 12-24 hours, or as a continuous infusion of 2 mg/kg/24 hours. 1, 4
  • The elimination half-life in neonates is approximately 6.6 hours, supporting less frequent dosing than in older children. 4
  • Continuous infusion maintains more stable gastric pH than intermittent bolus dosing in this population. 4

Special Clinical Contexts

Anaphylaxis (Adjunctive Therapy)

  • Children: 1 mg/kg IV (12.5-50 mg maximum) over 5 minutes as second-line therapy after epinephrine. 5, 6, 7
  • Adults: 50 mg IV diluted in 5% dextrose over 5 minutes. 5, 7
  • Never administer H2 antagonists alone for anaphylaxis; they are adjunctive to epinephrine. 6, 7

Continuous Infusion

  • For Zollinger-Ellison or severe hypersecretory states: Start at 1 mg/kg/hour, titrating upward in 0.5 mg/kg/hour increments based on gastric acid output. 1
  • Doses up to 2.5 mg/kg/hour have been used safely. 1
  • For standard acid suppression in neonates: 2 mg/kg/24 hours as continuous infusion. 1, 4

Renal Impairment Adjustments

For creatinine clearance <50 mL/min, reduce dosing to 50 mg every 18-24 hours (or proportionally reduce per-kilogram doses). 1, 8

  • Ranitidine elimination half-life increases approximately 3-fold in renal failure (from ~2-3 hours to 7 hours). 8
  • Renal clearance correlates significantly with creatinine clearance. 8
  • Time hemodialysis doses to coincide with the end of dialysis sessions. 1

Administration Guidelines

Intermittent IV bolus: Dilute to ≤2.5 mg/mL and inject over 5 minutes (no faster than 4 mL/min). 1

Intermittent IV infusion: Dilute to ≤0.5 mg/mL and infuse over 15-20 minutes. 1

Continuous infusion: Dilute to ≤2.5 mg/mL for standard dosing. 1

Critical Pitfalls

  • Avoid standard every-8-hour dosing in critically ill children—more frequent dosing (every 6 hours) or continuous infusion provides superior acid suppression. 3, 2
  • Monitor gastric pH directly in high-risk patients, as clinical response varies significantly with age and renal function. 3
  • Younger patients and those with impaired renal function require dose adjustments—age and kidney function significantly affect achievement of therapeutic pH. 3
  • The FDA maximum of 50 mg per dose applies even to larger children and adolescents. 6, 1

References

Research

Evaluation of Intravenous Ranitidine on Gastric pH in Critically Ill Pediatric Patients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2019

Guideline

Ranitidine Alternatives and Historical Prescribing Information

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intramuscular Ranitidine Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ranitidine Administration in Special Clinical Contexts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of ranitidine in patients with renal failure.

Journal of clinical pharmacology, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.